Oncotype DX

oncotype DX Home / Services – Oncology For patients with early-stage (I, II, or IIIa), HR (hormone receptor)-positive, HER2-negative breast cancer that is either node-negative or node-positive (1-3 nodes). CONTACT NOW Learn more Reasons to get tested The Breast Recurrence Score test is the only test proven to predict chemotherapy benefit. Studies have consistently shown […]

Precision Medicine

Precision medicine Home / Services – Oncology Transforming cancer treatment for solid and liquid biopsy Help oncologists and patients select the best treatments, therapies with tests from CAP-accredited lab in the US following NCCN Guidelines with over 400 publications. Contact now Learn more Why is it important? Patients who have reachedstage IIIB or beyond Identifying […]

Hereditary Cancer Screening

Hereditary cancer screening Home / Services – Oncology The test screens for up to 84 genes of common inherited cancers, by the Next Gene Sequencing (NGS) (SMSEQTM). Hereditary cancer screening Detecting Early Cancer Risks With Hereditary Test Learn more Contact now The tetsing of 2 genes related to the genetic predisposition of breast cancer are […]

Hereditary Breast Cancer

HOME / SERVICES – ONCOLOGY The breast cancer gene test is connected to the genetic predisposition of breast cancer, called BRCA1 and BRCA2. From that test result, the genetic counselor and doctor also support you with methods of prevention and early diagnosis. Screening and early diagnosis of Hereditary Breast Cancer Risk Learn more CONTACT NOW […]

Guardant 360

HOME / SERVICES – ONCOLOGY Survey Implementation Process New Hope For End Stage Cancer Patients. Learn more CONTACT NOW The Guardant360® assay is a breakthrough liquid biopsy that provides fast, accurate and comprehensive genomic results from a simple blood draw in approximately seven days upon receipt in the US laboratory. Since its launch in 2014, […]